Brief: Venus Medtech Hangzhou Posts HY Loss Attributable RMB199.9 Million
31/08/2022 16:22
Aug 31 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK :
* HY LOSS ATTRIBUTABLE RMB199.9 MILLION VERSUS LOSS RMB113.1
MILLION
* HY REVENUE RMB210 MILLION VERSUS RMB239.3 MILLION
Further company coverage: 2500.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market